How Indian Drugmakers Can Capitalize on Patent Expiry
India’s pharmaceutical industry is preparing to tap into a massive global opportunity. A patent cliff worth $63.7 billion is set to hit the U.S. drug market. Experts say Indian drugmakers are well-positioned to benefit. What Is a Patent Cliff? A patent cliff occurs when major drugs lose their patent protection. This allows other companies to […]